Q Therapeutic System for Chronic Stroke Recovery
Part of paid clinical trials in White Plains, New York.
- Sponsor
- Burke Rehabilitation Hospital
- Study ID
- NCT06979466
- Status
- Recruiting
Conditions
- Brain Injury
- Cerebrovascular Accident (CVA)
- Chronic Stroke Patient
- Hemorrhage
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Q Therapeutic System (BQ 3.0) - Active — DEVICEThe BQ 3.0 is a medical device that produces and delivers non-invasive, extremely low intensity and frequency (1-100 Hz.; 0.1-1.0 G), frequency tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery
Study Details
Evaluate the effectiveness of the Q Therapeutic (BQ 3.0) System for individuals with chronic stroke in improving upper extremity function as determined by change in functional outcome measures after 3-month treatment, including in-clinic and at-home sessions.
Key Dates
- Start date
- May 26, 2025
- Status verified
- Aug 2025
- Primary completion
- May 31, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: BQ 3.0 Active Stimulation Group60 sessions over a period of 12 weeks (5 treatments per week) of active study intervention with the BQ 3.0 (frequency and intensity parameters will be set to 1-100 Hz.; 0.1-1.0 G), including a standardized, pre-defined and evidence-based physical and occupational therapy regimen concurrent with the study intervention.
Primary Outcome Measure
Fugl-Meyer Assessment - Upper Extremity [ Time Frame: Baseline, 3 month, 5 month, 6 month ]
Central Contacts
- Josette Hartnett, MPH9145972367
- Andrew Abdou, DO7327137373
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Burke Rehabilitation Hospital | White Plains | New York | 10605 | Andrew Abdou, DO (PRINCIPAL_INVESTIGATOR) Mooyeon Oh-Park, MD, MHCM (SUB_INVESTIGATOR) |
Find similar trials in White Plains, NY
By condition
By specialty
By research site
Related Studies
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic AphasiaRecruiting · City University of New York · New York, New York